The tumor suppressor p53 regulates c-Maf and Prox-1 to control lens differentiation

Current Molecular Medicine

Volumn 12, Issue 8, 2012, Pages 917-928

  Liu, F Y ^a   Tang, X C ^a   Deng, M ^b,c   Chen, P ^b   Ji, W ^b   Zhang, X ^b   Gong, L ^b,d   Woodward, Z ^b   Liu, J ^b,e   Zhang, L ^b,f   Sun, S ^b,g   Liu, J P ^b   Wu, K ^a   Wu, M X ^a   Liu, X L ^a   Yu, M B ^a   Liu, Yizhi ^a   Li, David Wan Cheng ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e INSTITUTE OF TROPICAL BIOSCIENCE AND BIOTECHNOLOGY   (China)

^f FUDAN UNIVERSITY   (China)

^g CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

c Maf; Cataract; Cell differentiation; Gene regulation; Lens; Lens differentiation; p53; Prox 1; Transcription regulation; Tumor suppressor

Indexed keywords

CRYSTALLIN; LUCIFERASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR C MAF; TRANSCRIPTION FACTOR PROX1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; BIOASSAY; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; KNOCKOUT MOUSE; LENS; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN DNA BINDING; REGULATORY MECHANISM; TUMOR SUPPRESSOR GENE;

ANIMALS; ANTIGENS, DIFFERENTIATION; BASE SEQUENCE; BINDING SITES; CELL DIFFERENTIATION; CELL LINE; CONSERVED SEQUENCE; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, REPORTER; HOMEODOMAIN PROTEINS; HUMANS; LENS, CRYSTALLINE; LUCIFERASES, RENILLA; MICE; MICE, KNOCKOUT; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MAF; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

MURINAE; MUS;

EID: 84866529773     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/156652412802480835     Document Type: Article

References (108)

1. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer 2002; 2: 594-604.
2. Oren M. Decision making by p53: life, death and cancer. Cell Death Differ 2003; 10: 431-42.
3. Manfredi JJ. p53 and apoptosis: it's not just in the nucleus anymore. Mol Cell 2003; 11: 552-4.
4. Miyashita T, Krajewski S, Krajewska M, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994; 9: 1799-805.
5. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80: 293-9.
6. Wu GS, Burns TF, McDonald ER 3rd, et al. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet 1997; 17: 141-3.
7. Wen-Schaub LB, Zhang W, Cusack JC, et al. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol 1995; 15: 3032-40.
8. Buckbinder L, Talbott R, Velasco-Miguel S, et al. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 1995; 377: 646-9.
9. Israeli D, Tessler E, Haupt Y, et al. A novel p53-inducible gene, PAG608, encodes a nuclear zinc finger protein whose overexpression promotes apoptosis. EMBO J 1997; 16: 4384-92.
10. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature 1997; 389: 300-5.
11. Qin J-C, He-Ge Chen, Deng M, et al. Protein phosphatase-2A is a target of epigallocatechin-3-gallate and modulates the p53-Bak apoptotic pathway. Cancer Res 2008; 68: 4150-62.
12. Deng M, Chen PC, Liu FY, et al. The p53-Bak apoptotic signaling axis plays an essential role in regulating differentiation of the ocular lens. Curr Mol Med 2012; 12(8) [E-pub ahead of print].
13. Riley T, Sontag E, Chen P and Levine A. Transcriptional control of human p53-regulated genes. Nature Rev Mol & Cell Biol 2008; 9: 402-12.
14. Mihara M, Erster S, Zaika A, et al. p53 has a direct apoptogenic role at the mitochondria. Mol Cell 2003; 11: 577-90.
15. Shen Y, White E. P53-dependent apoptosis pathways. Adv Cancer Res 2005; 82: 55-84.
16. Haffner R, Oren M. Biochemical properties and biological effects of p53. Curr Opin Genet Dev 1995; 5: 84-90.
17. Waga S, Hannon GJ, Beach D, Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 1994; 369: 574-8.
18. Maeda T, Hanna AN, Sim AB, et al. GADD45 regulates G2/M arrest, DNA repair, and cell death in keratinocytes following ultraviolet exposure. J Invest Dermatol 2002; 119: 22-6.
19. Salvador JM, Hollander MC, Nguyen AT, et al. Mice lacking the p53-effector gene Gadd45a develops a lupus-like syndrome. Immunity 2002; 16(4): 499-508.
20. Smith ML, Ford JM, Hollander MC, et al. p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes. Mol Cell Biol 2000; 20: 3705-14.
21. Parker SB, Eichele G, Zhang P, et al. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 1995; 267: 1024-7.
22. Halevy O, Novitch BG, Spicer DB, et al. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 1995; 267: 1018-21.
23. Soddu S, Blandino G, Scardigli R, et al. Interference with p53 protein inhibits hematopoietic and muscle differentiation. J Cell Biol 1996; 134: 193-204.
24. Ruiz-Lozano P, Hixon ML, Wagner MW, et al. p53 is a transcriptional activator of the muscle-specific phosphoglycerate mutase gene and contributes in vivo to the control of its cardiac expression. Cell Growth Differ 1999; 10: 295-306.
25. Cam H, Griesmann H, Beitzinger M, et al. p53 family members in myogenic differentiation and rhabdomyosarcoma development. Cancer Cell 2006; 10: 281-93.
26. Shaulsky G, Goldfinger N, Peled A, Rotter V. Involvement of wild-type p53 in pre-B-cell differentiation in vitro. Proc Natl Acad Sci USA 1991; 88: 8982-6.
27. Aloni-Grinstein R, Schwartz D, Rotter V. Accumulation of wild-type p53 protein upon gamma-irradiation induces a G2 arrest-dependent immunoglobulin kappa light chain gene expression. EMBO J 1995; 14: 1392-401.
28. Gao Y, Ferguson DO, Xie W, et al. Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature 2000; 404: 897-900.
29. Quang CT, Wessely O, Pironin M, Beug H, Ghysdael J. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit liganddependent proliferation. EMBO J 1997; 16: 5639-53.
30. Metz T, Harris AW, Adams JM. Absence of p53 allows direct immortalization of hematopoietic cells by the myc and raf oncogenes. Cell 1995; 82: 29-36.
31. Weiss MJ, Orkin SH. Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. Proc Natl Acad Sci USA 1995; 92: 9623-7.
32. Wan Z, Zhi N, Wong S, et al. Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors. J Clin Invest 2010; 120: 3530-44.
33. Chae HD, Lee MR, Broxmeyer HE. 5-Aminoimidazole-4-carboxyamide ribonucleoside induces G(1)/S arrest and Nanog downregulation via p53 and enhances erythroid differentiation. Stem Cells 2012; 30: 140-9.
34. Li DW-C, Liu J-P, Schmid PC, et al. Protein Serine/Threonine Phosphatase-1 Dephosphorylates p53 at Ser-15 and Ser-37 to Modulate its Transcriptional and Apoptotic Activities. Oncogene 2006; 25: 3006-3022.
35. Li DW-C, Liu J-P, Mao YW, et al. Calcium-Activated RAF/MEK/ERK pathway mediates p53-dependent apoptosis and is abrogated by alpha B-crystallin through Inhibition of Ras Activation. Mol Biol Cell 2005; 16: 4437-53.
36. Li DW, Fass U, Huizar I, Spector A. Okadaic acid induced lens epithelial cell apoptosis requires inhibition of protein phosphatase 1 and is associated with altered gene expression including p53 and bax. Eurr J Biochem 1998; 257: 351-361.
37. Nishizawa M, Kataoka K, Goto N, Fujiwara KT, Kawai S. vmaf, a viral oncogene that encodes a "leucine zipper" motif. Proc Natl Acad Sci USA 1989; 86: 7711-5.
38. Fujiwara KT, Kataoka K, Nishizawa M. Two new members of the maf oncogene family, mafK and mafF, encode nuclear b-Zip proteins lacking putative trans-activator domain. Oncogene 1993; 8: 2371-80.
39. Kataoka K. Multiple mechanisms and functions of maf transcription factors in the regulation of tissue-specific genes. J Biochem 2007; 141: 775-81.
40. Cvekl A, Duncan MK. Genetic and epigenetic mechanisms of gene regulation during lens development. Prog Retin Eye Res 2007; 26: 555-97.
41. Kataoka K, Noda M, Nishizawa M. Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun. Mol Cell Biol 1994; 14: 700-12.
42. Igarashi K, Kataoka K, Itoh K, Hayashi N, Nishizawa M, Yamamoto M. Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins. Nature 1994; 367: 568-72.
43. Kataoka K, Fujiwara KT, Noda M, Nishizawa M. MafB, a new Maf family transcription activator that can associate with Maf and Fos but not with Jun. Mol Cell Biol 1994; 14: 7581-91.
44. Kataoka K, Shioda S, Yoshitomo-Nakagawa K, Handa H, Nishizawa M. Maf and Jun nuclear oncoproteins share downstream target genes for inducing cell transformation. J Biol Chem 2001; 276: 36849-56.
45. Nishizawa M, Kataoka K, Vogt PK. MafA has strong cell transforming ability but is a weak transactivator. Oncogene 2003; 22: 7882-90.
46. Aramata S, Han SI, Yasuda K, Kataoka K. Synergistic activation of the insulin gene promoter by the beta-cell enriched transcription factors MafA, Beta2, and Pdx1. Biochim Biophys Acta 2005; 1730: 41-6.
47. Han SI, Yasuda K, Kataoka K. ATF2 interacts with beta-cellenriched transcription factors, MafA, Pdx1, and beta2, and activates insulin gene transcription. J Biol Chem 2011; 286: 10449-56.
48. Kamitani-Kawamoto A, Hamada M, Moriguchi T, et al. MafB interacts with Gcm2 and regulates parathyroid hormone expression and parathyroid development. J Bone Miner Res 2011; 26: 2463-72.
49. Yoshida K, Imaki J, Koyama Y, et al. Differential expression of maf-1 and maf-2 genes in the developing rat lens. Invest Ophthalmol Vis Sci 1997; 38: 2679-83.
50. Kim JI, Li T, Ho IC, Grusby MJ, Glimcher LH. Requirement for the c-Maf transcription factor in crystallin gene regulation and lens development. Proc Natl Acad Sci USA 1999; 96: 3781-5.
51. Kawauchi S, Takahashi S, Nakajima O, et al. Regulation of lens fiber cell differentiation by transcription factor c-Maf. J Biol Chem 1999; 274: 19254-60.
52. Xie Q, Cvekl A. The orchestration of mammalian tissue morphogenesis through a series of coherent feed-forward loops. J Biol Chem 2011; 286: 43259-71.
53. Ring BZ, Cordes SP, Overbeek PA, Barsh GS. Regulation of mouse lens fiber cell development and differentiation by the Maf gene. Development 2000; 127: 307-17.
54. Takeuchi T, Kudo T, Ogata K, et al. Neither MafA/L-Maf nor MafB is essential for lens development in mice. Genes Cells 2009; 14: 941-7.
55. Tomarev SI, Zinovieva RD, Chang B, Hawes NL. Characterization of the mouse Prox1 gene. Biochem Biophys Res Commun 1998; 248: 684-9.
56. Wigle JT, Chowdhury K, Gruss P, Oliver G. Prox1 function is crucial for mouse lens-fibre elongation. Nat Genet 1999; 21: 318-22.
57. Cang Y, Zhang J, Nicholas SA, et al. Deletion of DDB1 in mouse brain and lens leads to p53-dependent elimination of proliferating cells. Cell 2006; 127: 929-40.
58. Geatrell JC, Gan PM, Mansergh FC, et al. Apoptosis gene profiling reveals spatio-temporal regulated expression of the p53/Mdm2 pathway during lens development. Exp Eye Res 2009; 88: 1137-51.
59. Nakamura T, Pichel JG, Williams-Simons L, Westphal H. An apoptotic defect in lens differentiation caused by human p53 is rescued by a mutant allele. Proc Natl Acad Sci USA 1995; 92: 6142-6.
60. Reichel MB, Ali RR, D'Esposito F, et al. High frequency of persistent hyperplastic primary vitreous and cataracts in p53-deficient mice. Cell Death Differ 1998; 5: 156-62.
61. Pan H, Griep AE. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev 1994; 8: 1285-99.
62. Yan Q, Gong L, Mi Deng, et al. Sumoylation activates the transcriptional activity of p32 isoform of the paired box gene 6 (Pax-6), an important transcription factor for eye and brain development. Proc Natl Acad Sci USA 2010; 107: 21034-9.
63. Wen-Feng Hu, Gong Lili, Cao Z, et al.-Crystallins interact with caspase-3 and Bax to guard mouse lens development. Curr Mol Med 2012; 12: 177-187.
64. Xiao L, Gong LL, Yuan D, et al. Protein phosphatase-1 regulates Akt1 signal transduction pathway to control gene expression, cell survival and differentiation. Cell Death Differ 2010; 17: 1448-62.
65. Feng H, Xiang H, Ying-Wei Mao, et al. Human Bcl-2 activates RAF/MEK/ERK pathway and regulates AP-1 activity and downstream genes in rabbit Lens epithelial cells. Oncogene 2004; 23: 7310-21.
66. Chen H-G, Han W-J, Deng M, et al. Transcriptional Regulation of PP2A-A α is mediated by multiple factors including AP-2α, CREB, ETS, and SP-1. PLoS One 2009; 4: e7019.
67. Zhang L, Sun S, Zhou J, et al. Knockdown of Akt1 Promotes Akt2 Upregulation and Resistance to Oxidative Stress-Induced Apoptosis through Control of Multiple Signaling Transduction Pathways. Antioxidants & Redox Signaling 2011; 15: 1-14.
68. Sto sequester their translocation during staurosporine-induced apoptosis. Cell Death and Differ 2004; 11: 512-26.
69. de Longh R, McAvoy JW. Spatio-temporal distribution of acidic and basic FGF indicates a role for FGF in rat lens morphogenesis. Dev Dyn. 1993; 198:190-202.
70. Ali RR, Sowden JC. Regenerative medicine: DIY eye. Nature 2011; 472: 42-3.
71. Eiraku M, Takata N, et al. Self-organizing opticcupmorphogenesis in three-dimensional culture. Nature 2011; 472: 51-6.
72. Yang C, Yang Y, Brennan L, Bouhassira EE, Kantorow M, Cvekl A. Efficient generation of lens progenitor cells and lentoid bodies from human embryonic stem cells in chemically defined conditions. FASEB J 2010; 24: 3274-83.
73. Chow RL, Lang RA. Early eye development in vertebrates. Annu Rev Cell Dev Biol 2001; 17: 255-296.
74. Gunhaga L. The lens: a classical model of embryonic induction providing new insights into cell determination in early development. Philos Trans R Soc Lond B Biol Sci 2011; 366: 1193-203.
75. Medina-Martinez O, Jamrich M. Foxe view of lens development and disease. Development 2007; 134: 1455-63.
76. Ashery-Padan R, Marquardt T, Zhou X, Gruss P. Pax6 activity in the lens primordium is required for lens formation and for correct placement of a single retina in the eye. Genes Dev 2000; 14: 2701-11.
77. Hill RE, Favor J, Hogan BL, et al. Mouse small eye results from mutations in a paired-like homeobox-containing gene. Nature 1991; 354: 522-5.
78. Hogan BL, Hirst EM, Horsburgh G, Hetherington CM. Small eye (Sey): a mouse model for the genetic analysis of craniofacial abnormalities. Development 1998; 103: 115-9.
79. Quinn JC, West JD, Hill RE. Multiple functions for Pax6 in mouse eye and nasal development. Genes Dev 1996: 10: 435-46.
80. Yan Q, W-B Liu, Qin J, et al. Protein Phosphatase-1 dephosphorylates Pax-6, a transcription factor controlling brain and eye development. J Biol Chem 2007; 282: 13954-65.
81. Shaham O, Smith AN, Robinson ML, Taketo MM, Lang RA, Ashery-Padan R. Pax6 is essential for lens fiber cell differentiation. Development 2009; 136: 2567-78.
82. Collinson JM, Quinn JC, Buchanan MA, et al. Primary defects in the lens underlie complex anterior segment abnormalities of the Pax6 heterozygous eye. Proc Natl Acad Sci USA 2001; 98: 9688-93.
83. Liu W, Lagutin OV, Mende M, Streit A, and Oliver G. Six3 activation of Pax6 expression is essential for mammalian lens induction and specification. EMBO J 2006; 25: 5383-95.
84. Streit A. Early development of the cranial sensory nervous system: from a common field to individual placodes. Dev Biol 2004; 276: 1-15
85. Cui X, Zhang J, Du R, et al. HSF4 is involved in DNA damage repair and cataract formation via regulation of rad51. Biochim Biophy Acta 2012; 1822:1308-1315.
86. Cvekl A, Mitton KP. Epigenetic regulatory mechanisms in vertebrate eye development and disease. Heredity 2010; 105: 135-51.
87. Czerny T, Busslinger M. DNA-binding and transactivation properties of Pax-6: three amino acids in the paired domain are responsible for the different sequence recognition of Pax-6 and BSAP (Pax-5). Mol Cell Biol 1995; 15: 2858-71.
88. Ring BZ, Cordes SP, Overbeek PA, Barsh GS. Regulation of mouse lens fiber cell development and differentiation by the Maf gene. Development 2000; 127: 307-17.
89. Eychène A, Rocques N, Pouponnot C. A new MAFia in cancer. Nat Rev Cancer 2008; 8: 683-93.
90. Gillies SD, Morrison SL, Oi VT, Tonegawa S. A tissuespecific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell 1983; 33: 717-28.
91. Singh H, Sen R, Baltimore D, Sharp PA. A nuclear factor that binds to a conserved sequence motif in transcriptional controls elements of immunoglobulin genes. Nature 1986; 319:154-8.
92. Kusakabe M, Hasegawa K, Hamada M, et al. c-Maf plays a crucial role for the definitive erythropoiesis that accompanies erythroblastic island formation in the fetal liver. Blood 2011; 118: 1374-85.
93. Ise W, Kohyama M, Schraml BU, et al. The transcription factor BATF controls the global regulators of class-switch recombination in both B cells and T cells. Nat Immunol 2011; 12: 536-43.
94. Rani A, Afzali B, Kelly A, et al. IL-2 regulates expression of C-MAF in human CD4 T cells. J Immunol 2011; 187: 3721-9.
95. Suzuki A, Iida S, Kato-Uranishi M, et al. ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma. Oncogene 2005; 24: 6936-44.
96. Wilting J, Papoutsi M, Christ B, et al. The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues. FASEB J 2002; 16: 1271-3.
97. Francois M, Harvey NL, Hogan BM. The transcriptional control of lymphatic vascular development. Physiology (Bethesda). 2011; 26: 146-55.
98. Mishima K, Watabe T, Saito A, et al. Prox1 induces lymphatic endothelial differentiation via integrin alpha9 and other signaling cascades. Mol Biol Cell 2007; 18: 1421-9.
99. Westmoreland JJ, Kilic G, Sartain C, et al. Pancreas-specific deletion of Prox1 affects development and disrupts homeostasis of the exocrine pancreas. Gastroenterology 2012; 142: 999-1009.
100. Risebro CA, Petchey LK, Smart N, et al. Epistatic Rescue of Nkx2.5 Adult Cardiac Conduction Disease Phenotypes by Prospero-Related Homeobox Protein 1 and HDAC3. Circ Res 2012; [Epub ahead of print].
101. Glucksmann A. Cell deaths in normal vertebrate ontogeny. Biol Rev 1951; 26: 59-86.
102. Silver J, AFW Hughes. The role of cell death during morphogenesis of the mammalian eye. J Morph 1973; 140: 159-70.
103. Ishizaki Y, Voyvodic JT, Burne JF, Raff MC. Control of lens epithelial cell survival. J Cell Biol 1993; 121: 899-908.
104. Ozeki H, Ogura Y, Hirabayashi Y, Shimada S. Suppression of lens stalk cell apoptosis by hyaluronic acid leads to faulty separation of the lens vesicle. Exp Eye Res 2001; 72: 63-70.
105. Bozanic D, Tafra R, Saraga-Babic M. Role of apoptosis and mitosis during human eye development. Eur J Cell Biol 2003; 82: 421-9.
106. Mohamed YH, Amemiya T. Apoptosis and lens vesicle development. Eur J Ophthalmol 2003; 13: 1-10.
107. Yan Q, Liu J-P, Li DW-C. Apoptosis in lens development and pathology. Differentiation 2006; 74: 195-211.
108. Zhang L, Yan Q, Liu JP, et al. Apoptosis: Its Functions and Control in the Ocular Lens. Curr Mol Med 2010; 10: 864-75.